ARCHIVES

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

March 5, 2010

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

Private Institute Commits $1 Million Pick Up some NIH Grants Left Unfunded

April 19, 1985

Matted Lymph Nodes Can Predict Survival Rate, Spread of Disease

January 27, 2012

Otis Brawley To Succeed Harmon Eyre As American Cancer Society’s Chief Medical Officer.

August 3, 2007